We are live on ! Find out more
RCM

Radcliffe Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 1.18%
This Fund
S&P 500
This Quarter Est. Return
-6.4%
1 Year Est. Return
+1.18%
3 Year Est. Return
+4.94%
5 Year Est. Return
-24.37%
10 Year Est. Return
-27.33%
AUM
$3.16B
AUM Growth
-$986M
Cap. Flow
-$1.33B
Cap. Flow %
-42%
Top 10 Hldgs %
11.28%
Holding
1,211
New
25
Increased
127
Reduced
57
Closed
330

Top Buys

Rank Stock Value
1
NHIC
NewHold Investment Corp. II Class A Common Stock
NHIC
+$8.21M
2
WQGA
World Quantum Growth Acquisition Corp.
WQGA
+$6.59M
3
ASCB
A SPAC II Acquisition Corp. Ordinary Shares
ASCB
+$6.15M
4
ACDI
Ascendant Digital Acquisition Corp. III
ACDI
+$5.44M
5
TVGN icon
Tevogen Inc. Common Stock
TVGN
+$5.13M

Top Sells

Rank Stock Value
1
GGMC
Glenfarne Merger Corp. Class A Common Stock
GGMC
+$20.3M
2
EDNC
Endurance Acquisition Corp. Class A Ordinary Shares
EDNC
+$15M
3
SIER
Sierra Lake Acquisition Corp. Class A Common Stock
SIER
+$14.5M
4
BTWN
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
+$14.4M
5
ASZ
Austerlitz Acquisition Corporation II
ASZ
+$13.3M

Sector Composition

Rank Sector Weight
1 Financials 49.85%
2 Industrials 3.61%
3 Technology 3.56%
4 Healthcare 3%
5 Materials 0.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOXO.WS
851
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
$94.8K ﹤0.01%
250,000
– –
LLAP.WS
852
DELISTED
Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
LLAP.WS
$79K ﹤0.01%
50,000
-45,899
-48% -$7.08K
VENAW
853
DELISTED
Venus Acquisition Corporation Warrant
VENAW
$68.8K ﹤0.01%
55,000
-10,000
-15% -$760
ML.WS
854
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$66.6K ﹤0.01%
107,359
– –
BZFDW icon
855
BuzzFeed Inc Warrant
BZFDW
$643K
$65.6K ﹤0.01%
95,115
– –
COEPW
856
DELISTED
Coeptis Therapeutics Warrants
COEPW
$57.4K ﹤0.01%
37,500
-37,400
-50% -$2.5K
BBAI.WS icon
857
BigBear.ai Holdings Warrant
BBAI.WS
$43.5M
$54.1K ﹤0.01%
80,330
– –
CDIOW icon
858
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$892K
$53K ﹤0.01%
50,000
– –
CMRAW
859
DELISTED
Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027
CMRAW
$49.2K ﹤0.01%
40,000
– –
APGNW
860
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$36.6K ﹤0.01%
53,688
– –
GETR.WS
861
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$36.3K ﹤0.01%
58,140
-1,860
-3% -$220
GROV.WS
862
DELISTED
Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50
GROV.WS
$34.5K ﹤0.01%
86,373
– –
GLS.WS
863
DELISTED
Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
$29K ﹤0.01%
100,000
– –
BOXD.WS
864
DELISTED
Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share
BOXD.WS
$17K ﹤0.01%
87,468
– –
SWVLW icon
865
Swvl Holdings Corp Warrant
SWVLW
$11.8K ﹤0.01%
86,420
– –
QNGY.WS
866
DELISTED
Quanergy Systems, Inc. Warrants, each whole warrant exercisable for one twentieth (1/20) share of Common Stock at an exercise price of $230.00 per full share
QNGY.WS
$8.37K ﹤0.01%
162,500
– –
AFRI icon
867
Forafric Global
AFRI
$301M
– –
-76,669
Closed -$863K
ALTI icon
868
AlTi Global
ALTI
$493M
– –
-749,995
Closed -$7.43M
ALVOW icon
869
Alvotech Warrant
ALVOW
– –
-73,073
Closed -$494K
PARA
870
Banzai International
PARA
$5.83M
– –
-59
Closed -$5.83M
CDIO icon
871
Cardio Diagnostics
CDIO
$5.3M
– –
-3,333
Closed -$1M
DFLI icon
872
Dragonfly Energy
DFLI
$18.9M
– –
-224
Closed -$208K
DRTSW icon
873
Alpha Tau Medical Warrant
DRTSW
$79.6M
– –
-60,700
Closed -$354K
ESLA icon
874
Estrella Immunopharma
ESLA
$31.1M
– –
-100,000
Closed -$1.01M
EUDA icon
875
EUDA Health Holdings
EUDA
$47.6M
– –
-5,000
Closed -$1M
33 34
35
36 37

Similar funds

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $1.34B AUM 12.81% 1-Year Est. Return
BFMH
Baring Fintech Manager Holding Castel, Guernsey $1.34B AUM 20.23% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
HAM
HoldCo Asset Management Fort Lauderdale, Florida $1.34B AUM 28.06% 1-Year Est. Return
VHAM
Van Hulzen Asset Management El Dorado Hills, California $1.35B AUM 22.73% 1-Year Est. Return

Radcliffe Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Radcliffe Capital Management held 1,211 positions worth $3.16B, down 24% from $4.15B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Radcliffe Capital Management withdrew a net $1.33B in Q4 2022, closing 330 positions and reducing 57 holdings. Its most notable exit was Glenfarne Merger Corp. Class A Common Stock, an estimated $20.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 50% of assets, down from 54% a quarter earlier, followed by Industrials and Technology.

Against the trend, Radcliffe Capital Management opened a new position in A SPAC II Acquisition Corp. Ordinary Shares worth $6.24M.

  • Radcliffe Capital Management's largest Q4 2022 buy was A SPAC II Acquisition Corp. Ordinary Shares: 609,909 shares worth $6.24M.
  • Radcliffe Capital Management added most to NewHold Investment Corp. II Class A Common Stock in Q4 2022, an estimated $8.21M increase.
  • Radcliffe Capital Management's biggest Q4 2022 reduction was Focus Impact BH3 Acquisition Company Class A Common Stock, cutting an estimated $7.13M.
  • Radcliffe Capital Management fully exited Glenfarne Merger Corp. Class A Common Stock in Q4 2022, selling an estimated $20.3M.
  • Radcliffe Capital Management's ten largest holdings make up 11% of its $3.16B portfolio in Q4 2022.
  • Radcliffe Capital Management opened 25 new positions and closed 330 in Q4 2022.
  • Radcliffe Capital Management's portfolio value fell 24% quarter-over-quarter to $3.16B.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.